The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Malaria, Cerebral

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Malaria, Cerebral


Psychiatry related information on Malaria, Cerebral


High impact information on Malaria, Cerebral


Chemical compound and disease context of Malaria, Cerebral


Biological context of Malaria, Cerebral


Anatomical context of Malaria, Cerebral


Gene context of Malaria, Cerebral


Analytical, diagnostic and therapeutic context of Malaria, Cerebral


  1. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. Warrell, D.A., Looareesuwan, S., Warrell, M.J., Kasemsarn, P., Intaraprasert, R., Bunnag, D., Harinasuta, T. N. Engl. J. Med. (1982) [Pubmed]
  2. Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. Grau, G.E., Frei, K., Piguet, P.F., Fontana, A., Heremans, H., Billiau, A., Vassalli, P., Lambert, P.H. J. Exp. Med. (1990) [Pubmed]
  3. Specificity of hypoglycaemia for cerebral malaria in children. Kawo, N.G., Msengi, A.E., Swai, A.B., Chuwa, L.M., Alberti, K.G., McLarty, D.G. Lancet (1990) [Pubmed]
  4. Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Eckwalanga, M., Marussig, M., Tavares, M.D., Bouanga, J.C., Hulier, E., Pavlovitch, J.H., Minoprio, P., Portnoï, D., Rénia, L., Mazier, D. Proc. Natl. Acad. Sci. U.S.A. (1994) [Pubmed]
  5. Big endothelin in patients with complicated Plasmodium falciparum malaria. Wenisch, C., Wenisch, H., Wilairatana, P., Looareesuwan, S., Vannaphan, S., Wagner, O., Graninger, W., Schönthal, E., Rumpold, H. J. Infect. Dis. (1996) [Pubmed]
  6. Psychosis after cerebral malaria in children. Sowunmi, A. Journal of the National Medical Association. (1993) [Pubmed]
  7. A trial of artemether or quinine in children with cerebral malaria. van Hensbroek, M.B., Onyiorah, E., Jaffar, S., Schneider, G., Palmer, A., Frenkel, J., Enwere, G., Forck, S., Nusmeijer, A., Bennett, S., Greenwood, B., Kwiatkowski, D. N. Engl. J. Med. (1996) [Pubmed]
  8. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. Gordeuk, V., Thuma, P., Brittenham, G., McLaren, C., Parry, D., Backenstose, A., Biemba, G., Msiska, R., Holmes, L., McKinley, E. N. Engl. J. Med. (1992) [Pubmed]
  9. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Treutiger, C.J., Heddini, A., Fernandez, V., Muller, W.A., Wahlgren, M. Nat. Med. (1997) [Pubmed]
  10. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. McGuire, W., Hill, A.V., Allsopp, C.E., Greenwood, B.M., Kwiatkowski, D. Nature (1994) [Pubmed]
  11. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Ockenhouse, C.F., Tandon, N.N., Magowan, C., Jamieson, G.A., Chulay, J.D. Science (1989) [Pubmed]
  12. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Grau, G.E., Fajardo, L.F., Piguet, P.F., Allet, B., Lambert, P.H., Vassalli, P. Science (1987) [Pubmed]
  13. Phenobarbital for children with cerebral malaria. Verhoef, H., West, C.E., Kok, F.J. Lancet (2000) [Pubmed]
  14. Nitric oxide and cerebral malaria. Clark, I.A., Cowden, W.B., Rockett, K.A. Lancet (1993) [Pubmed]
  15. Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lopansri, B.K., Anstey, N.M., Weinberg, J.B., Stoddard, G.J., Hobbs, M.R., Levesque, M.C., Mwaikambo, E.D., Granger, D.L. Lancet (2003) [Pubmed]
  16. Pathophysiological and prognostic significance of cerebrospinal-fluid lactate in cerebral malaria. White, N.J., Warrell, D.A., Looareesuwan, S., Chanthavanich, P., Phillips, R.E., Pongpaew, P. Lancet (1985) [Pubmed]
  17. Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. Ockenhouse, C.F., Tegoshi, T., Maeno, Y., Benjamin, C., Ho, M., Kan, K.E., Thway, Y., Win, K., Aikawa, M., Lobb, R.R. J. Exp. Med. (1992) [Pubmed]
  18. Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria. Burgner, D., Usen, S., Rockett, K., Jallow, M., Ackerman, H., Cervino, A., Pinder, M., Kwiatkowski, D.P. Hum. Genet. (2003) [Pubmed]
  19. Expression of major histocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria. Monso-Hinard, C., Lou, J.N., Behr, C., Juillard, P., Grau, G.E. Immunology (1997) [Pubmed]
  20. Intragastric mefloquine is absorbed rapidly in patients with cerebral malaria. Chanthavanich, P., Looareesuwan, S., White, N.J., Warrell, D.A., Warrell, M.J., DiGiovanni, J.H., von Bredow, J. Am. J. Trop. Med. Hyg. (1985) [Pubmed]
  21. Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism. Picot, S., Peyron, F., Donadille, A., Vuillez, J.P., Barbe, G., Ambroise-Thomas, P. Immunology (1993) [Pubmed]
  22. In vivo sequestration of Plasmodium falciparum-infected human erythrocytes: a severe combined immunodeficiency mouse model for cerebral malaria. Willimann, K., Matile, H., Weiss, N.A., Imhof, B.A. J. Exp. Med. (1995) [Pubmed]
  23. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. Anstey, N.M., Weinberg, J.B., Hassanali, M.Y., Mwaikambo, E.D., Manyenga, D., Misukonis, M.A., Arnelle, D.R., Hollis, D., McDonald, M.I., Granger, D.L. J. Exp. Med. (1996) [Pubmed]
  24. Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier. Medana, I.M., Chan-Ling, T., Hunt, N.H. Am. J. Pathol. (2000) [Pubmed]
  25. Tumour necrosis factor-alpha and macrophages in Plasmodium berghei-induced cerebral malaria. Curfs, J.H., Hermsen, C.C., Kremsner, P., Neifer, S., Meuwissen, J.H., Van Rooyen, N., Eling, W.M. Parasitology (1993) [Pubmed]
  26. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. Engwerda, C.R., Mynott, T.L., Sawhney, S., De Souza, J.B., Bickle, Q.D., Kaye, P.M. J. Exp. Med. (2002) [Pubmed]
  27. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. Barnwell, J.W., Asch, A.S., Nachman, R.L., Yamaya, M., Aikawa, M., Ingravallo, P. J. Clin. Invest. (1989) [Pubmed]
  28. TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. Lucas, R., Lou, J., Morel, D.R., Ricou, B., Suter, P.M., Grau, G.E. J. Leukoc. Biol. (1997) [Pubmed]
  29. Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria. Jakobsen, P.H., McKay, V., Morris-Jones, S.D., McGuire, W., van Hensbroek, M.B., Meisner, S., Bendtzen, K., Schousboe, I., Bygbjerg, I.C., Greenwood, B.M. Infect. Immun. (1994) [Pubmed]
  30. Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. Ball, H.J., MacDougall, H.G., McGregor, I.S., Hunt, N.H. J. Infect. Dis. (2004) [Pubmed]
  31. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Crawley, J., Waruiru, C., Mithwani, S., Mwangi, I., Watkins, W., Ouma, D., Winstanley, P., Peto, T., Marsh, K. Lancet (2000) [Pubmed]
  32. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Grau, G.E., Pointaire, P., Piguet, P.F., Vesin, C., Rosen, H., Stamenkovic, I., Takei, F., Vassalli, P. Eur. J. Immunol. (1991) [Pubmed]
  33. Increased c-fos expression in the brain during experimental murine cerebral malaria: possible association with neurologic complications. Ma, N., Harding, A.J., Pamphlett, R., Chaudhri, G., Hunt, N.H. J. Infect. Dis. (1997) [Pubmed]
  34. A complement receptor-1 polymorphism with high frequency in malaria endemic regions of Asia but not Africa. Thomas, B.N., Donvito, B., Cockburn, I., Fandeur, T., Rowe, J.A., Cohen, J.H., Moulds, J.M. Genes Immun. (2005) [Pubmed]
  35. Serum neopterin, interleukin-4, and interleukin-6 concentrations in cerebral malaria patients and the effect of iron chelation therapy. Thuma, P.E., Weiss, G., Herold, M., Gordeuk, V.R. Am. J. Trop. Med. Hyg. (1996) [Pubmed]
WikiGenes - Universities